PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings
Session Recording from PHA's 2010 9th International PH Conference

Changing to Different PH Medications: Important
Things to Know Before, During and After

June 26, 2010 

A wealth of effective and approved PH medications is currently available to PH patients and many new experimental medications are on the way. For patients already on a medication, there may be a reason to switch to another medication, such as failure to improve, side-effects, or the complex nature of some medications. In this session, we will explore and discuss questions around the issue of switching PH medications.

The below recording will begin automatically. To view the controls, move your mouse anywhere over the video then move to the control interface at the bottom of the video.



Presenter Information

Victor Tapson, MD (Chair) Dr. Victor Tapson
Murali Chakinala, MD
Kelly Chin, MD
Helena Purl, RN, BSN, CCRC 

>>If you liked this recording, you may enjoy Taking an Active Role in Your Healthcare Decisions

Taking an Active Role in Your Healthcare Decisions panelists





Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.